Cognitive enhancers, also known as nootropics, are emerging as promising tools in addiction recovery. These substances aim to improve cognitive functions like memory, attention, and decision-making, which are often impaired by prolonged substance use. Medications such as modafinil, bupropion, and acetylcysteine have shown potential in reducing cravings and supporting cognitive recovery. These drugs work by modulating neurotransmitter systems, including dopamine and glutamate, to restore balance in the brain. Cognitive training programs, combined with these enhancers, further boost recovery outcomes by strengthening executive functions. While research is ongoing, the integration of cognitive enhancers offers a novel dimension to addiction treatment, improving both neurological health and quality of life.
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College and NEALAC Clinic , United States
Title : The effect of Balint training on self-efficacy and empathy among medical students and the moderator role of personality traits and choice of specialty
Meni Koslowsky, Ariel University, Israel
Title : Sexualizing anxiety and anxiolytic sex: Misattribution of arousal
Sam Vaknin, Commonwealth Institute of Advanced Professional Studies, United Kingdom
Title : Dr Jekyll and Mr. Hyde revealed: Tales from the default mode network
Christopher Ashton, TeDDs on Chapel, Centre for Recovery, Canada
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Addiction and the failure of meaning-forming
Jenni Guentcheva, GoodNeighbor LLC, United States